Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
复制标题
DOI:
10.1530/eje-13-0309
复制
发表时间:
2013-11-01
影响因子:
5.8
通讯作者:
Chen, Min-Chi
中科院分区:
文献类型:
--
作者:
Lu, Chang-Hsien;Lee, Kuan-Der;Chen, Min-Chi
OBJECTIVE: Most studies on second primary malignancies (SPMs) after primary thyroid cancer were conducted in USA or Europe. The discrepancy between SPMs in these studies could be attributed to geographical and ethnic heterogeneity. Thus, there is a clear need for another large-scale epidemiological study, particularly in Asian countries, to define the incidence and risk of SPMs in thyroid cancer survivors.DESIGN: A population-based study was conducted using the nation-wide database from Taiwan Cancer Registry between 1979 and 2006.METHODS: We quantified standardized incidence ratios (SIRs) and cumulative incidence of SPMs among 19,068 individuals (4205 males and 14,863 females) with primary thyroid cancer.RESULTS: A total of 644 cases (3.38%) developed at least a SPM during 134,678 person-years of follow-up. The risk for subsequent SPMs was significantly greater than that of the general population (SIR=1.33, 95% CI 1.23-1.44). There was a greater risk of developing major salivary glands, nasopharyngeal, lung, thymus, breast (females), bladder, and brain cancers, and leukemia and lymphoma. We observed that the risk was highest within the first 5 years of diagnosis of thyroid cancer (SIR=5.29, 1.68, and 0.68 for ≤ 5, 5-10, and >10 respectively) and in the younger patients (SIR=1.81 vs 1.61 for